CHANGING SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA ISOLATES FROM CYSTIC-FIBROSIS PATIENTS WITH THE CLINICAL USE OF NEWER ANTIBIOTICS

被引：32

作者：

BOSSO, JA

ALLEN, JE

MATSEN, JM

机构：

[1] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112

[2] UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84112

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1989年 / 33卷 / 04期

关键词：

D O I：

10.1128/AAC.33.4.526

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

收藏

页码：526 / 528

页数：3

相关论文

共 17 条

[1] ABSENCE OF RAPIDLY DEVELOPING RESISTANCE DURING TREATMENT OF CYSTIC-FIBROSIS PATIENTS WITH AZTREONAM
ALLEN, JE
BOSSO, JA
SAXON, BA
MATSEN, JM
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 8 (01) : 51 - 55
[2] ARONOFF SC, 1984, ANTIMICROB AGENTS CH, V25, P279, DOI 10.1128/AAC.25.2.279
[3] BLESSING J, 1981, MONOGR PAEDIATR, V14, P115
[4] BOSSO JA, 1987, AM J MED, V82, P180
[5] CONTROLLED TRIAL OF AZTREONAM VS TOBRAMYCIN AND AZLOCILLIN FOR ACUTE PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS
BOSSO, JA
BLACK, PG
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1988, 7 (03) : 171 - 176
[6] INVITRO ACTIVITY OF AZTREONAM COMBINED WITH TOBRAMYCIN AND GENTAMICIN AGAINST CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA AND PSEUDOMONAS-CEPACIA FROM PATIENTS WITH CYSTIC-FIBROSIS
BOSSO, JA
SAXON, BA
MATSEN, JM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) : 1403 - 1405
[7] CONTROLLED TRIAL OF CEFTAZIDIME VS TICARCILLIN AND TOBRAMYCIN IN THE TREATMENT OF ACUTE RESPIRATORY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS
GOLD, R
OVERMEYER, A
KNIE, B
FLEMING, PC
LEVISON, H
[J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (02) : 172 - 177
[8] HODSON ME, 1987, LANCET, V1, P235
[9] HOIBY N, 1982, ACTA PAEDIATR SC S, V301, P33
[10] KRILOV LR, 1985, REV INFECT DIS S3, V7, P482